Predict your next investment


See what CB Insights has to offer


Acquired | Acquired

Total Raised




About Progen Pharmaceuticals

Progen Pharmaceuticals, fka CellGate, is a Redwood City, California-based biotechnology company with oncology assets based on epigenetic and polyamine inhibition. On February 4, 2008, CellGate was acquired by TBG Diagnostics at a valuation of $1.5M.

Progen Pharmaceuticals Headquarter Location

3 Twin Dolphin Drive Suite 100

Redwood City, California, 94065,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.